LISTEN TO THE Event Speakers 2023
Prof. Ibrahim A. Alsarra
Chairman of Scientific Committee
Prof. Ibrahim A. Alsarra
Chairman of Scientific Committee
Chairman of Scientific Committee
Professor of Pharmaceutical Biotechnology
College of Pharmacy
King Saud University
Professor Ibrahim A. Alsarra received his Bachelor of Pharmacy (B.S.), in 1996 from College of Pharmacy, King Saud University, Kingdom of Saudi Arabia and his Doctor of Philosophy (Ph.D.) in Pharmaceutical Biotechnology and Drug Formulation Development, Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Missouri, USA.
He joined King Saud University in 2002 and was the Assistant Secretary for Research and Scientific Affairs, Arab Pharmacists Union as well as the Deputy Director for Research and Technical Affairs, Centre of Excellence in Biotechnology Research; the only biotechnology center in Saudi Arabia, King Saud University till 2021. He was the President of Saudi Pharmaceutical Society for two terms and the former Editor-in-Chief of Saudi Pharmaceutical Journal for six years, a peer-reviewed and ISI-Indexed Journal with an impact factor of 4.33.
Research Interests:
Professor Alsarra research interests include; Pharmaceutical Biotechnology; Biosimilars and Biological medications, Drug Delivery, and Controlled Drug Release.
Brief Research Achievements Summary:
Professor Alsarra has more than 13 registered patent: (five)-US Patents, (Four)-European Patents, and (Four)- Saudi Patents. He has published and eadited several
book and bookchapters and several peer-reviewed paper in highly reputed journals (more than 186 peer-reviewed papers).
Some Selected Grants Awarded:
* Best Editor-in-Chief (2014), of the scientific journals hosted by King and Saud University and published by Elsevier, King Saud University, Riyadh, Saudi
Arabia.
* Recipient of King Saud University’s Award for Distinguished Scientific Research: Invention Section (faculty members across the University (2014), King Saud University, Riyadh, Saudi Arabia.
* Scientist of the Year (2014), organized by Dubai International Pharmaceuticals
and Technologies Conference and Exhibition (DUPHAT 2014), Dubai Health Authority, Dubai, United Arab Emirates.
* Recipient of King Saud University’s Award for Distinguished Research and High-
quality International Publications by faculty members across the University (2009), King Saud University, Riyadh, Saudi Arabia.
* Outstanding Scientists, International Biographical Centre, Cambridge, England (2000)
*Leading Scientists of the World (2008), Research and Editorial Departments, International Biographical Centre, Cambridge, England.
* International Scientist of the Year (2007), International Biographical Center, Cambridge, England.
* Recipient of his Royal Highness Prince Bandar Bin Sultan Award, Saudi Ambassador to the USA, for outstanding academic achievement during Doctoral studies, 2003.
* Rho Chi Society, the Pharmacy Honor Society, 2000 University of Missouri-Kansas City, Missouri 64110-2265, USA (Academic Honor).
Dr. Lamya Alomair
Head of AI and Bioinformatics, KAIMRC
Dr. Lamya Alomair
Head of AI and Bioinformatics, KAIMRC
Dr. Lamya is recognized in Saudi Arabia as an
influencer and innovator in the field of technology.
She has an extensive list of accomplishments,
participating in numerous national technological
projects, collaborating with different healthcare
institutions and professionals globally. These
information health system projects have had a
positive impact on improving healthcare delivery,
assisting healthcare professionals to make more
efficient and effective decisions and to embrace
trending innovations in the field, enabling
successful digital transformations in Saudi Arabia
Dr. Lamya Alomair is currently the Head of AI and Bioinformatics at King Abdullah International Medical Research Center (KAIMRC), and an affiliated faculty member at George Mason University, USA. her work was featured in several international media, including first edition by MIT Technology Review, In 2022, with her deep knowledge analytics she was picked as one of the "Top 30 Leading Arab Experts in AI 2022" and Member at Fast Company Middle East Impact Council dedicated to AI.
Dr. Alomair is one of the first Saudi women to obtain a Bachelor Degree in Computer Science, from KSU, and later joined the Ministry of National Guard Health Affairs (MNGHA). She was one of only two Saudi female employees in her department. Her hard work and
dedication enabled her to overcome various obstacles in her early career. This in turn had a huge impact on the role of women in healthcare and technology projects.
Dr. Lamya Alomair focused on trending topics such as Big Data, and related initiatives and projects. Then she joined in the field of Health Informatics by obtaining a Master’s Degree
in Health Informatics from KSAU-HS in 2007. She participated in a few national initiatives in the field of Health Informatics. These initiatives led her towards advancing the field of Computational Biology in Saudi. In 2017, Dr. Alomair earned her PhD in Bioinformatics and
Computational Biology from GMU, USA.
Dr. Alomair has been examining the rapidly evolving field of A.I, exploring its current and potential applications in healthcare sectors. She is organizing many symposiums and workshops in the field of AI &. She is an active supporter and enabler in the fields of both A.I. and Big Data. She regularly promotes AI & Bioinformatics as a guest speaker at the College of Nursing in KSAU-HS.
Dr. Alomair serves on several national committees to build AI and Bioinformatics national strategy development. She utilizes her excellent communication skills and actively involving in building various strategies for collaboration nationally and internationally. She
also offers her expertise to healthcare projects and research consultancy to promote the advancements and implementations.
Mr. Anas Batikhi
Founder & CEO, SANTECHTURE
Mr. Anas Batikhi
Founder & CEO, SANTECHTURE
Over 25 years of information technology experience in healthcare and finance sectors. Anas held several senior technical roles working for leading organizations such as Eli Lilly and GlaxoSmithKline Pharmaceuticals. He then moved to the investment banking industry to lead on the development and implementation of the trading platforms for Millennium Global Investments, a large Hedge Fund in the City of London with USD 14 Billion under management.
Before SANTECHTURE, he co-founded ACCUMED in the UAE and led the business RCM operations and technology for the UAE and spearheaded expansion into KSA In his capacity as the General Manager between 2010 and 2021.
Anas has a bachelor degree in Computing and Information Systems from Brighton University and MSc in Business Information Technology from Kingston Business School.
Dr. Wisam Al Badr
CMO, DaVita
Dr. Wisam Al Badr
CMO, DaVita
Dr. Al Badr has more than two decades of experience in healthcare. Currently serving as Chief Medical Officer for DaVita Care Saudi Arabia. Dr. Al Badr, earned her bachelors in Medicine and surgery in medicine from King Abdul Aziz University–Jeddah. Dr. Al Badr completed her residency training, Michigan (United States). She trained in nephrology and interventional nephrology at Saint Louis University, Missouri, USA. She progressed to be dual board certified in medicine and Nephrology by the ABIM (American Board of Internal Medicine & Nephrology). American Board of Internal Medicine and the American Society of Diagnostic and Interventional Nephrology. The area of interest is merge change management with quality principles and population healthcare. Dr. AlBadr is a practicing Consultant Adult Nephrologist, leader in Quality and Population Health Management and its application in nephrology practice and proficient in Change Management and Practicing Healthcare leader. At DaVita, Dr. Al Badr continue the path in quality management and established the integrated approach combining operational efficiency and clinical governance.
Dr. Sana Farid
Surgeon and Healthcare Futurist
Dr. Sana Farid
Surgeon and Healthcare Futurist
Dr. Sana Farid is a force to be reckoned with. Not only does she have the skills of a healer, but also the ability to make you see things in a whole new light. She's been named one of the top 100 voices in XR worldwide, and she pioneered the establishment of Immersive Technology-based programs for the Healthcare, Education, and Government sectors.
When she's not pushing the boundaries of innovation as a Surgeon and Author, Dr. Sana is making waves in the field of Immersive Technologies. She's one of those rare folks who can talk about the future and technology while also being a master of empathy and compassion. Dr. Sana is always prepared to dazzle and delight you with creative insights.
VR AR Association
A celebrated pioneer in Extended Reality (XR) and Ai in Healthcare, Dr. Sana Farid has been named one of the top 100 voices in XR worldwide. She pioneered the establishment of Immersive Technology-based programs for pediatrics, the critically ill, and special needs.
When she's not pushing the boundaries of innovation as a surgeon, author, and public speaker, Dr. Sana is making waves in the field of immersive technologies.
She's one of those rare folks who can talk about the future and technology while also being a master of empathy and compassion. Dr. Sana is always prepared to dazzle and delight you with creative insights.
Mr. Floris van der Breggen
CEO of SyncVR Medical
Mr. Floris van der Breggen
CEO of SyncVR Medical
Floris van der Breggen is founder and CEO of SyncVR Medical, the largest Virtual/Augmented Reality (XR) platform of healthcare in Europe. He has an academic background in psychology and computer science. From his first-ever side job in dementia care when he was 15 years old, he is endlessly motivated to improve healthcare internationally day by day, which led to founding SyncVR Medical in 2019, now becoming the de-facto standard platform for XR in healthcare.
Mr. Abdullah AL-Sharqi
Tawuniya, CTO
Mr. Abdullah AL-Sharqi
Tawuniya, CTO
Over 17 years of Experience in setting up and leading multi-Billion SAR transformation programs and organizations across different industries such as private health Insurance , Digital ,Real-estate, Housing,, Education, Telecom, in both government and private sectors. Proven experience in working with senior government officials, key entities in private sector, and building successful PPPs to achieve national agenda and develop business.
In Sep 2019 I have been assigned as the chief IT & digital transformation officer at CCHI to lead the setup of unified platform of the health and private health insurance which known now by “nphies” , the future of the digital health and private health in Saudi Arabia. This platform is been delivered through PPP model with the private sector with more than 4 billion SAR investment that connecting more than 16k entities in the country .furthermore I’m leading the digital transformation in the sector by developing digital strategy and offering a wide e-services to improve the sector performance via partnerships with leading semi government companies. Moreover back in 2017 I was appointed by H.E. Majid AL-Hoqail to establish the housing program in Saudi Vision 2030 where I have worked with multiple entities and stakeholders to articulate the program strategy, objectives, KPIs, KPTs, Initiatives, budget, and timeline. In addition to the execution of the program initiatives across 16 government entities and several parties from private sector (Banks, Real Estate Developer, Contractors, manufacturers, etc) with a budget of 185B SAR and a team of 50+ people. As part of the program, I have established and initiated several SBUs and PPPs to implement key initiatives and localize several industries.
Prior to joining government, I have worked in the management consulting at PwC ME as a manager where I have advised several entities in the government and private sectors covering strategy development, financial management and operations improvement. I have led a team from pwc network to rollout new consulting services in ME for digital age.
I have led the establishment of 2 private companies with a value of 100+ millions SAR ( alsharqi avenue , osimah) in digital services and real estate industries from developing and implementing a sound strategy, to putting together the right team and securing enough funding.
Dr. Burhan Fakhurji
Cancer Cell and Nucleic Acid Biologist,
Dr. Burhan Fakhurji
Cancer Cell and Nucleic Acid Biologist,
Founder and CEO of www.iGene-sa . More than 18 years of experience in Molecular Biology with a demonstrated history of working in the medical diagnostic lab at the Ministry of Health. Skilled in outbreak project planning, strong interpersonal skills with certification in employee mediation, team building and innovative problem solver.
Dr. Mohammed Alshehri
CISO & Cybersecurity Consultant to Taif University President
Dr. Mohammed Alshehri
CISO & Cybersecurity Consultant to Taif University President
CISO & Cybersecurity Consultant to Taif University President
Dr. Mohammad Dahman Alshehri is a Cybersecurity Consultant for the President of Taif University, Chief Information Security Officer (CISO) and Assistant Professor of Computer Science (AI-Based Cybersecurity) at Taif University, Saudi Arabia, He received his PhD in Artificial Intelligence of Cybersecurity for the Internet of Things (IoT) from the University of Technology Sydney, Australia. He developed 6 smart novel algorithms for IoT to reinforce Cybersecurity with AI that is able to detect the various behaviours of cyberattacks and provide a full security and protection platform for the IoT from the most harmful cyberattacks. Furthermore, he received two Patents for AI-Based Cybersecurity and IoT, and he published more than 60 publications in high-ranked international journals, top-tier conferences, and chapters of books, also he received a number of international and national awards and prizes. He is an IEEE Senior Member (SMIEEE), an Ambassador of Emerging Technologies at Stanford University, US, and a Fellow of the Higher Education Academy (FHEA), UK. His main current research interest lies in the areas of Cybersecurity, Artificial Intelligence, Internet of Things (IoT).
Abstract:
Healthcare field is one of the most important fields that related to our lives. Essentially, healthcare systems are struggling with many cyberattacks that cause disruption of the vital healthcare systems. This is an innovation system and method for the prevention of cyberattacks in real-time systems using artificial neural networks (ANN) for healthcare field. Technically, the system for prevention of cyberattacks in real-time systems using ANN comprises of a long-short term memory (LSTM) recurrent neural network module to detect the Black Hole attacks, Gray Hole attacks, an ANN wavelet-based neural network module to detect the Wormhole attacks, a LSTM recurrent neural network module to detect the Denial of Service attacks. Moreover, the innovation is using to protect healthcare systems form the most harm cyberattacks such as ransomware. This innovated patent for prevention of cyberattacks in real-time systems using ANN wherein the analysis of the potential cyberattacks comprises steps of: decompiling the potential cyberattacks within the isolation hypervisor; determining that the potential cyberattacks corresponds to actual cyberattacks; determining a signature unique to the actual cyberattacks; storing the signature unique to the actual cyberattacks; tracing a route path of the actual cyberattacks and determining a source of the actual cyberattacks.
Dr. Harpreet Sood
MD, MPH, MRCGP
Dr. Harpreet Sood
MD, MPH, MRCGP
Harpreet is currently Vice President, Primary Care at Huma and a National Health Service (NHS) primary care doctor. Harpreet is also a Visiting Lecturer at Imperial College London Business School and a Board Member at Wesleyan, a financial services mutual organisation.
Harpreet was formerly the first Associate Chief Clinical Information Officer (CCIO) at NHS England, and prior to that, Senior Fellow to the Chief Executive Officer of NHS England, where he advised senior NHS policymakers on NHS innovation and technology policy. As the Associate CCIO, Harpreet was involved in and developing and implementing NHS England's digital health and data strategy, including co-founding and leading on the NHS Digital Academy. Harpreet has been an advisor to the UK Covid Vaccine programme and a board member at Health Education England, a $5.5bn organisation training and educating 160,000 staff across the NHS. Here his focus is on developing digital and data science skills and training for the NHS workforce.
Harpreet has worked in the US where he co-founded a digital health startup in Boston and worked at Brigham and Women's Hospital.
Harpreet trained as a clinical doctor at King’s College London and Imperial College Business School and completed a Masters in Public Health (MPH) at Harvard University.
Harpreet has over 30 published papers in peer reviewed journals including the British Medical Journal (BMJ), Lancet, Nature, Digital Medicine and the Journal
of the American Medical Informatics Association (JAMIA).
Dr. Ali Alhasan
CEO, NanoPalm Ltd.
Dr. Ali Alhasan
CEO, NanoPalm Ltd.
Dr. Ali H. Alhasan is the founder and CEO of the NanoPalm Ltd. and an associate professor at King Abdualziz City for Science and Technology (KACST), the co-founder of the KACST-BWH/Harvard center of excellence for biomedicine, a principal investigator of the nanomedicine R&D group, and an adjunct professor at Alfaisal University. He is a nanoscientist with PhD in nanomedicine and research interests in nanomaterials, who is known for his discovery and development of three patented inventions; 1) scannometric miRNA-based biodetection and therapeutic, 2) immune suppressing nanoparticles for robust sensitization of drug-resistant breast cancer, and 3) patterning-mediated supramolecular assembly of lipids into nanoparticles. Dr. Alhasan received his B.S. degree from King Abdulaziz University (2001), an M.S. and a Ph.D. degrees from Northwestern University (2008 and 2015, respectively). He completed his PhD studies in the laboratory of Professor Chad Mirkin, who has founded 10 companies and has been recognized with over 250 national and international awards, including the 2023 King Faisal Prize. Dr. Alhasan joined the Center of Excellence in Nanomedicine (CENM) as the director of strategic initiatives, and as a postdoctoral researcher in the laboratory of Professor Adah Almutairi at University of California-San Diego, CA, USA. Dr. Alhasan has been the recipient of recognitions including the International Institute for Nanotechnology Outstanding Researcher, and a Kemin outstanding researcher. His researches produced published papers in high impact journals like Science Advances, PNAS, ACS Nano, JACS, Small, iScience, RSC Biomaterials, Analytical Chemistry, RSC Advances in Nanotechnology, and Scientific Reports. He has given over 100 invited lectures and educated over 50 researchers, graduate students, and postdoctoral fellows, of whom over 15 are now members at top institutions within the Kingdome of Saudi Arabia, including NEOM, KAUST, KACST, and the Saudi FDA.
Mr. Karim Dakki
Klaim, CEO
Mr. Karim Dakki
Klaim, CEO
" Karim Dakki - Being an instinctive leader, Karim has a glaring 15-year record of accomplishments in highly demanding environments of private equity and technology management. With his relentless commitment to excellence and execution, he co-founded a Myanmar-based telecom company valued at 700m USD and has delivered outstanding results as an acting CFO in multiple startups and organizations."
Dr. Abdullah Alfarhan
Pharmacist and Continuing Professional Development Officer
Dr. Abdullah Alfarhan
Pharmacist and Continuing Professional Development Officer
Pharmacist and Continuing Professional Development Officer Almoosa Specialist Hospital
Almoosa Specialist Hospital
Pharmacy Automation: Whats Beyond That?
Manual medication dispensing is rife with challenges. It’s tedious, repetitive, and error-prone. However, pharmacy automation changed the game for pharmacy operations. By using technology, pharmacists and their staff can spend their time on more high-level work to improve patient outcomes. With the support of automation, care management becomes more feasible. Pharmacists focus more attention on complex patients and preventative services. It’s critical to dispensing and care management. Find out why. What are the benefits of implementing automation in pharmacy? How can automation improve employee productivity & work? Automated pharmacy: Is it a burden or profit? How can you use automation efficiency?
Dr. Imane Boudellioua
Assistant Professor, KFUPM
Dr. Imane Boudellioua
Assistant Professor, KFUPM
Dr. Imane Boudellioua is an Assistant Professor in the Information and Computer Science Department at King Fahd University of Petroleum and Minerals, and one of the founding female faculty members at KFUPM. She holds a PhD degree in Computer Science from King Abdullah University of Science and Technology, where she was awarded KAUST Discovery Scholarship, KAUST MSc/PhD Fellowship, and KAUST Provost Award. She is the recipient of 2020 KACST-AlMarai Prize for Scientific Creativity for her PhD thesis on machine learning methods for the prioritization of candidate causative genomic variants of Mendelian and oligogenic diseases. She is also one of the winners of KAUST TAQADAM Accelerator Program for her startup, GenomeFit, providing AI-empowered genetic diagnostics services. Her research interests are in computational genomics, and the application of machine learning and data mining in the biomedical field.
Prof. Mazen Hassanain
Managing Director
Prof. Mazen Hassanain
Managing Director
Prof. Mazen Hassanain, MBBS, FRCS(C), FACS, Ph.D.
Professor Mazen M. Hassanain is the founder and Managing Director of SaudiVax, a pioneer Saudi biotechnology company responsible for developing and manufacturing high-quality and affordable halal vaccines & biopharmaceuticals localized in Saudi Arabia by Saudi nationals for national self-sufficiency and pandemic preparedness. He is also a Professor of Surgery at the College of Medicine, King Saud University, an Adjunct Professor at the Department of Pediatrics at Baylor College of Medicine, and a formal Adjunct Professor at the Department of Oncology at McGill University. Prof. Hassanain is also a hepatopancreatobiliary and solid organ transplant surgery Consultant at the King Saud University Medical City.
He is an experienced clinician-scientist with a demonstrated history of working in hospitals, research centers, and the healthcare industry. Skilled in collaborative translational, immunology, and oncology research and development projects, and is success-driven. Strong educational background with a Doctor of Philosophy (Ph.D.) focused on moving scientific research from bench to bed. He received his medical degree with honors from King Saud University and did his surgical residency and transplantation fellowship at McGill University, Montreal, Canada. He is a Fellow of The Royal College of Physicians of Canada and a Fellow of the American College of Surgeons, a member of the American Society of Transplant Surgery Associations. Prof. Hassanain is also a member of the LANCET-COVID-19 commission.
Before SaudiVax, Prof. Hassanain worked at the Saudi Ministry of Health from 2012 to 2014 as the Director-General, of the General Administration of Research and Studies. He was leading the health research strategy for Saudi Arabia, deciding on priorities, and inserting needed regulatory measures to protect patients and improve the research quality. Initiated the health services research center, central ethics review board, and the national biobank. Prof. Hassanain co-established the Saudi Vaccine Alliance, a scientific and corporate group leading the vaccine research and supply discussions in the Kingdom.
In the last 10 years, he has presented 60 orals/posters at national and international meetings, resulting in 110 peer-reviewed publications and supervised hundreds of graduate and postgraduate students both in Saudi Arabia and Canada.
Dr. Zakiuddin Ahmed
Director, Riphah Institute of Healthcare Improvement
Dr. Zakiuddin Ahmed
Director, Riphah Institute of Healthcare Improvement
Adjunct Professor Digital Health, HSA
CEO, Digital Care Director,
Riphah Institute of Healthcare Improvement & Safety
Ex. Director Digital Health, KSA Riyadh
Zakiuddin Ahmed is a visionary strategist, healthcare entrepreneur & a physician advocate who specializes in developing socially beneficial, sustainable & innovative solutions in Healthcare through information technology with a Patient Centric Focus. His areas of expertise are Digital Health, Patient Safety, Ethics & Research. As an invited speaker he has presented at many conferences around the world and serves on the boards of various international conferences and organizations. He is the President, Healthcare Paradigm; Project Director, Riphah Institute of Healthcare Improvement & Safety, Program Director ? RAH@H at King Saud University Riyadh; Director Digital Health at PharmEvo; CEO of Digital Care; & Project Director of RAHAT. He also holds leadership positions as President, Healthcare Quality & Safety Association of Pakistan; Founding trustee of eHealth Association of Pakistan, Secretary Health Research Advisory Board. Dr. Zaki has a Bachelor's degree in Medicine and a Master's degree in Health Management.
Dr. Mohammed Alfadli
SFDA
Dr. Mohammed Alfadli
SFDA
تطبيق تقنية انترنت الأشياء لقياس درجة الحرارة والرطوبة على المنشآت العاملة في أنشطة نقل وتخزين الغذاء والدواء والأجهزة الطبية وذلك من خلال منصة وصل، بحيث تمكن الهيئة العامة للغذاء والدواء والجهات ذات العلاقة من ضبط ومراقبة هذا النشاط لرفع جودة وأمان وسلامة عمليات النقل والتخزين. وذلك للمساهمة في جودة الرقابة وضمان مأمونية المنتجات التي تقع تحت رقابة الهيئة ومتابعتها الكترونياً.
Dr. Anas Albarrak
Neurology Consultant
Dr. Anas Albarrak
Neurology Consultant
Neurology Consultant, Epileptologist, Intraoperative Neurophysiologist
Biography:
Dr. Anas Albarrak, MD, assistant professor, Prince Sattam bin Abdulaziz University, EEG director, King Khalid University Hospital, King Saud University Medical City (KSUMC), and the founder and CEO of Neurology Solutions Company.
Dr. Albarrak graduated from the college of medicine, King Saud University. He is certified by the Saudi and European Board of Neurology. He did Epilepsy and EEG fellowship at the University of London Ontario, Canada. Also, he did Intraoperative neurophysiology monitoring fellowship at the University of Pittsburgh, Pittsburgh, Pennsylvania, US.
He is very passionate about filling the gap in neurological care in Saudi Arabia and GCC countries by making neurology services available to everyone with the best quality. He has a special interest in artificial intelligence (AI) in health care in general and in neurology in particular.
Dr. Abdulrhman Aljouie
Associate Research Scientist, KAIMRC
Dr. Abdulrhman Aljouie
Associate Research Scientist, KAIMRC
Associate Research Scientist, KAIMRC
Dr. Abdulrhman Aljouie is a Research Scientist at King Abdullah International Medical Research Center and Assistant Professor of Computer Science (joint appointment) at King Saud bin Abdulaziz University for Health Sciences. Dr. Aljouie research interest lies in the area of Medical Artificial Intelligence. Including the development of multimodal deep learning networks for disease risk prediction using genomic and imaging data. His work in machine learning has been published at ttop peer-reviewed journals. Dr. Aljouie serves on several national committees pertaining to AI and Bioinformatics national strategy development. He holds a M.Sc. in Bioinformatics and a Ph.D. in Computer Science from New Jersey Institute of Technology, Newark, NJ, USA.
Mr. Wael Kabli
CEO, Cura Healthcare
Mr. Wael Kabli
CEO, Cura Healthcare
CEO, Founder of Cura Healthcare, Digital Health, Speaker, Entrepreneur, KFUPM-er, ex-Microsoft
Wael A. Kabli is an entrepreneur and an innovation & technology advisor. Currently, CEO and founder of his second startup called Cura (http://cura.healthcare) a telehealth company that aims to empower health communications changing the way patients and doctors interact, diagnose, prescribe, and conduct well-being therapy sessions. Wael also co-founded Xceed Ventures a company that used to perform big data, and social media, News, and TV analytics to measure public opinion. He worked as an architect and a technology advisor in Microsoft Consulting Services, advising for the top public and private sectors organizations in Saudi Arabia such as the Ministry of Interior, Ministry of Foreign Affairs, Aramco, SABIC, King Abdullah University of Science and Technology, Capital Market Authority, National Commercial Bank, Saudi Telecom Company STC, and more than 45 other advisory projects.
Dr. Mouhamad Ghyath Jamil
Consultant, KFSHRC
Dr. Mouhamad Ghyath Jamil
Consultant, KFSHRC
Consultant Pulmonary, Critical Care and sleep Medicine
Director Tele-ICU program
Director Transplant ICU
Clinical Assistant Professor of Internal Medicine University of North Dakota
Adjunct Assistant professor Al-Faisal University
King Faisal Hospital and Research Center, Riyadh, Saudi Arabia
Dr. Mouhamad Ghyath Jamil graduated from Aleppo University, Syria. After finishing his residency in internal medicine at University of North Dakota, he joined the university as an associate professor. Dr. Jamil finished his fellowship in Pulmonary, Critical Care and sleep Medicine at George Washington University.
Dr. Bahjat Fakieh
Associate Professor, KAU
Dr. Bahjat Fakieh
Associate Professor, KAU
Bahjat Fakieh is working as an associate professor and the head of the information systems department at King Abdulaziz University in Jeddah - Saudi Arabia. Previously, Bahjat was working as a lecturer in Federation University in association with ATMC college campus in Sydney for 1.5 years to teach cloud computing for a postgraduate program. In addition, he was working as an Information Systems tutor in Macquarie University for 4.5 years.
His research interest is data analysis and digital transformation for business and healthcare. In addition, Bahjat is holding several globally recognized professional certificates in IT service management, as well as working as a coach for business development from the technology perspective.
Dr. Hina Zafar
Prosthodontics
Dr. Hina Zafar
Prosthodontics
Professor Dr Hina Zafar Raja is working in Department
of Prosthodontics, Institute of Dentistry CMH Lahore
Medical College, since 2008 till to date.
She graduated from de’ Montmorency College of Dentistry, Lahore, in 2000. She did her FCPS in Prosthodontics in 2007. She did Masters with Distinction in Fixed and Removable Prosthodontics, from King’s College London, UK. She has International Certification in Medical Teaching and Health Professional Education from University of Liverpool. She is also PhD Scholar in Molecular Biology and Biotechnology in University of Veterinary and Animal Sciences, Lahore, Pakistan.
She has a Certified Design Registration of a device at Pakistan Patent Office and US Patent Office. She is Innovation lead – ORIC, CMH LMC as well as In-charge House Officers Program at Institute of Dentistry CMH LMC, Lahore Pakistan. She also worked as In Charge of intra mural practice, CMH Lahore Medical College and Institute of Dentistry, Lahore.
She presented in various national and international conferences. She was immediate Past President of Pak Association for Dental Research (PADR), 2019-2020, which is Pakistan Chapter of International Association of Dental Research (IADR). She was also Immediate Past President of Pakistan Prosthodontics Association for 2019-2020. She was Chairperson, Scientific Committee for multiple international conferences, held within Pakistan and Treasurer for PADR in past.
She is a supervisor to FCPS Prosthodontics program since 2016 and examiner to MDS and FCPS programs.
She is Managing Editor of Journal Of Pakistan Prosthodontics Association, a reviewer to Pakistan Oral and Dental Journal (PODJ) and Journal of Dow University of Health Sciences (JDUHs). She has many publications to her credit.
Mohammad Ali Shalan
VP Digital Transformation
Mohammad Ali Shalan
VP Digital Transformation
VP Digital Transformation at Project Management Institute (PMI) - Saudi Chapter
Eng. Mohammed Shalan is a practitioner having more than 25 years with proven track record in managing large-scale multi-million programs and projects in complex environments as well in establishing and implementing TMOs and PMOs.
He is experienced in planning and executing transformation journeys in many sectors with a focus on Business Enterprises, Construction, Real Estate, Hospitality, Mortgage and Non-Profit organizations with intensive knowledge in related business functions, emerging technologies, smart cities and ESG Goals.
Mohammad also shared wealth experience throughout more than 100 conferences, papers, chapters and articles crowned by the edited book “Innovative and Agile Contracting for Digital Transformation and Industry 4.0” which was published by IGI-Global in 2021.
Dr. Waddah Albassam
Chief Medical Officer, Alphaiota
Dr. Waddah Albassam
Chief Medical Officer, Alphaiota
Senior Radiologist, Chief Executive ,Saudi Health Expert & Digital
Health in Government and private sectors
Dr. Waddah is a certified specialized radiologist in body and cardiac imaging, with strategic and practical clinical and administrative experience gained through a range of key medical positions across both government and private sectors.
As Alphaiota’s Chief Medical Office, he is responsible for developing and communicating clinical strategy, representing the healthcare professionals’ voice inside the company, and guiding product-market fit to seize opportunities and solve critical healthcare issues. With a Master’s Degree in Health Administration, Dr. Waddah is driven to empower the health sector with the technology and tools to deliver enhanced care.
Prof. Anis Koubaa
Executive Director of the Innovation Center, PSU
Prof. Anis Koubaa
Executive Director of the Innovation Center, PSU
Executive Director of the Innovation Center
Anis Koubaa is the Executive Director of the Innovation Center, the Research and Initiatives Center Director, and the leader and founder of the Robotics and Internet-of-Things Lab at Prince Sultan University. He is a Full Professor in Computer Science and has been working on several R&D projects on data science and unmanned systems, deep learning, robotics, and Internet-of-Things. He is a Senior Fellow of the Higher Education Academy of the UK.
Anis Koubaa received several awards, including (1) The AI Leadership Award and the Best AI Product Award in the AI and Cloud Expo May 2022, (2) Winner KAUST Challenge Award in Hajj and Umrah in 2021 (among 1300 teams) in Transport and Mobility Category and awarded by his Excellency Prince Khaled Alfaisal, the Governor of Makkah, (3) the Rector Best Teacher Award in 2016 at Prince Sultan University and (4) the Best Research Award in 2012 at Al-Imam University. He is also nominated in the carrier-based top 2% scientists list by Stanford University.
The current research interests of Anis Koubaa deal with developing automated solutions for logistics using drones and robots for delivery systems.
He presented several training programs on drones, data science, Python programming, deep learning, and several other technologies. He is known for his course series and books on the Robot Operating System (ROS).
Anis is the author of the ROSLink protocol that enables robots and drones to talk the cloud systems and develop cloud robotics solutions. He also leads AI projects on real-time face surveillance, vehicle detection, and license plate recognition. He also develops AI and automation solutions for smart cities, healthcare, and smart agriculture.
Ms. Walaa Alnasser
Ph.D. in Computer Science
Ms. Walaa Alnasser
Ph.D. in Computer Science
Ph.D. in Computer Science,
Arizona State University,
Privacy in Machine Learning Focus.
Walaa Alnasser is a General Manager of Business Intelligence and Decision Support at a government organization. With over ten years of experience, she has been published three scientific research papers as a first author. She got her Ph.D. from ARIZONA STATE UNIVERSITY, and her dissertation was about measuring and enhancing users' privacy in machine learning. Her current role as a General Manager of Business Intelligence and Decision Support is helping the organization utilize the data and support the decision-making by providing helpful insights.
Dr. Aliah Aldahash
Msc, BPharm, KSU
Dr. Aliah Aldahash
Msc, BPharm, KSU
Novel Therapies - Imperial College London
Pharmacy - King Saud University
Expertise in Cell and Gene Therapies, Bioinformatics, and Pharmacovigilance
Cell and gene therapies are game-changing treatment in health care; it corrects the root cause of illness at the molecular level. The correction at the molecular level came with the advances in technologies, starting with the generation of the first draft DNA sequence of the human genome. Researchers are designing studies to understand the genes in the human genome. Understanding the human genome, discovering novel proteins and developing novel therapy became less time-consuming and money-saving with the introduction of innovative technologies such as Artificial inelegance (AI)/ machine learning techniques and gene editing techniques. The talk will cover a brief of the current landscape of gene therapies and personalised medicine, machine learning techniques and possible application in the development of gene therapy, including novel protein discovery and treatment, and presenting the possibility of using gene editing tools like CRISPR, Clustered Regularly Interspaced Short Palindromic Repeats, with machine learning to predict the locality of the gene for accuracy.
Ms. Reenita Das
Vice President
Ms. Reenita Das
Vice President
Healthcare and Life Sciences Partner and Senior Vice President
Frost & Sullivan
Reenita Das is a healthcare futurist and strategist, passionate about changing the healthcare industry. She got voted the top 100 women in Femtech and Healthtech and the top 50 Healthcare strategists to follow in 2021. She has lived and worked in over 10 countries in the world, focusing on healthcare issues and working with public and private sector to implement growth change strategies. Das currently serves as Partner and Senior Vice President and is the first woman Partner at Frost & Sullivan. In addition, she is the Founder of GLOW (Growth and Innovation of Women) program. She is also on the Board of a non profit “High Tech High Heels” Silicon Valley that focuses on increasing gender diversity for STEM. She is also part of the Advisory Board in Arab Health.
In her current role, Das manages a global business and works largely with clients on futuristic scenarios and forecasts in understanding how healthcare will operate 20 years from today. She is focused heavily on rethinking consumer business models as healthcare makes a transition to health and identifying opportunities with companies outside of healthcare to bring solutions to the healthcare sector. She is also focusing heavily on showcasing “Femtech” and the growth opportunities from this new sector which includes advising femtech companies on the right strategies and commercial business models to success.
Dr. Faris Ali Bukhamsin
Conference supervisor
Dr. Faris Ali Bukhamsin
Conference supervisor
Dr. Faris Bukhamsin holds a bachelor's degree in Medicine and Surgery, and an Executive MBA degree from Prince Mohammad Bin Salman College of Business & Entrepreneurship. He is the CEO of Scientific Saudi, a leading science communication and marketing agency in Saudi, and works as a marketing consultant for several scientific public, private, and third sectos' organizations.
Mr. Khaldoon Bushnaq
Co-Founder at Alma Health
Mr. Khaldoon Bushnaq
Co-Founder at Alma Health
Khaldoon is the co-founder and CEO of Alma Health, a digital healthcare provider dedicated to transforming the lives of people with chronic conditions and their caregivers. Khaldoon earned his degree in software engineering from Carleton University in Canada and later an MBA from the University of Cambridge. His work experience includes top global and regional names in technology, where he has held both engineering and strategy positions. Prior to founding Alma Health, Khaldoon served as the Head of Strategy and Business Performance at Careem, the Middle East’s first unicorn.
Mr. Mohamed El Missaoui
Chief Operations Officer (COO)
Mr. Mohamed El Missaoui
Chief Operations Officer (COO)
Possessing 20+ years of experience in the insurance, banking and FMCG sectors, Mohamed El Missaoui joined Bupa Arabia in 2011 as the Director of Total Quality Management. Where he oversaw service operations areas related to customer service, mega accounts, membership fulfillment, and quality.
Mohamed also previously led a variety of assignment at Unilever MENA relating to the supply chain, ranging from distribution, logistics, and customer service to industrial engineering and quality.
Mr. Hakim Alhusan
Co-Founder, FlowMed Inc.
Mr. Hakim Alhusan
Co-Founder, FlowMed Inc.
Hakim Alhusan is a veteran in the ICT industry with over 30 years of experience and Global business exposure along this journey. He held senior executive posts at Zhone Technologies, Inc. the latest being VP MEA & Asia. Prior to Zhone, Mr. Alhusan held executive positions at Lucent Technologies Inc.’s INS division for the Middle East, Ascend Communication and Cisco Systems in Toronto and in the Middle East
Mr. Hakim is an advisor to the Chairman of Dictum Health Inc. – a developer of Next Generation Tele-health devices since January 2015.
In 2019, Hakim Alhusan co-founded FlowMed, Inc., an innovative ecosystem and delivery Platform as a Service (PaaS) with Electronic Health Record, Business and Augmented Intelligence. Thus, allowing a Primary Health Care engagement between patients and clinicians virtually through mobile devices and IoT.
Mr. Alhusan holds an Electronics Engineering degree from University of Central Florida, Orlando - USA
Mr. Muhammad Faisal Rashid
Chief Operating Officer
Mr. Muhammad Faisal Rashid
Chief Operating Officer
Faisal Rashid is the chief operating officer and member of the executive leadership team for DaVita Saudi
Arabia.
In addition to leading strategic operations, Faisal also leads the control functions for the business including
Strategy, IT, People Services, Clinical, Legal and Compliance teams. Faisal is the driving force behind our
people strategy and its alignment to key business imperatives and is instrumental in creating our unique culture and a world-class teammate experience.
Faisal joined DaVita in the US in 2015 and then moved to London in 2018 taking on the role of Chief People
Officer for DaVita International. Before moving to the DaVita Saudi Arabia team, Faisal also served as the GM
of DaVita Taiwan where he helped drive clinical outcomes and patient satisfaction to be industry best.
Prior to DaVita, Faisal spent over 15 years in strategic leadership roles in the US health insurance, banking, and
consulting services industries – engaging with large clients with international presence.
He has a master’s in business administration (MBA) from Drexel University in Philadelphia, PA.
Mr. Abdulhameed A Alhajji
Founder & CEO of Genome
Mr. Abdulhameed A Alhajji
Founder & CEO of Genome
Biomedical Engineer
Founder & CEO of Genome | Genetic tests specialised Center.
Mr. Mohammed Al Anazi
Head of Digital Strategy & Innovation
Mr. Mohammed Al Anazi
Head of Digital Strategy & Innovation
Master of Science in Project and Systems Engineering Management from the CUA, expert in Digital Strategy & Innovation, Digital Transformation, and Information Technology Products & Services. Certified in PMP, PRINCE2, ITIL, & Prosci® Certified Change Practitioner. He is one of the Founding Members of the Global Innovation Institute - KSA Chapter
Mr. Mohammed Abdulghaffar
General Manager
Mr. Mohammed Abdulghaffar
General Manager
General Manager of Entrepreneurship & Social Initiatives - Community Jameel Saudi
Eng. Basem Albiladi
Experienced in building new products and leading teams with a demonstrated history of working in the business management and entrepreneurship industry. Skilled in Negotiation, Entrepreneurship, Editing, Journalism, and Mobile Applications. Strong professional with a Bachelor's Degree in Electrical Engineering from Taibah University and over than 50 other courses in entrepreneurship, Leadership and project Management from different countries like (USA, United Kingdom, South Korea). He received his masters degree in entrepreneurship from Prince Mohammed Bin Salman College of Business and Entrepreneurship.
Mr. AlAbbas AlBarakati
Cloud Solutions
Mr. AlAbbas AlBarakati
Cloud Solutions
Planning and implementing digital transformation, sales, marketing and product development programs, both short and long range, targeted toward existing and new markets.